Center for Health, Exercise and Sport Sciences, Serbia   Report issue

Government Phase 2 Phase 3
Founded: Belgrade Serbia (2010)

Organization Overview

First Clinical Trial
2011
NCT01352065
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatigue (Phase 2)

Fatigue Syndrome, Chronic (Phase 2)

Hyperhomocysteinemia (Phase 3)

Hypertension, Pulmonary (Phase 3)

Obesity (Phase 3)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 10